Skip to main content

Advertisement

Log in

Paraoxonase 1 (PON1) polymorphisms and risk for migraine

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The polymorphic enzyme human serum paraoxonase 1 (PON1), encoded by the gene PON1 (chromosome 7q21.3) plays a role as an antioxidant molecule through several mechanisms. Because oxidative stress has been implicated in the pathogenesis of migraine, we have investigated the possible association between the nonsynonymous polymorphisms 55LM and 192QR in the PON1 and the risk for migraine. We studied the frequency of the PON1 genotypes and allelic variants in 197 patients with migraine and 220 healthy controls using a TaqMan single nucleotide polymorphism analysis. The frequencies of the PON1 genotypes and PON1 allelic variants did not differ significantly between patients with migraine and controls, and were unrelated with gender, family history of migraine, and presence or absence of aura. The frequencies of the genotype PON1 192QQ and the allelic variant PON1 192Q were significantly higher in patients with earlier onset of migraine. The results of the present study suggest that PON1 polymorphisms are not related with the risk for migraine in Caucasian Spanish people, although PON1 192Q/Q genotype and PON1 192Q allelic variant should be related with an earlier onset of migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adkins S, Gan KN, Mody M, La Du BN (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 52:598–608

    CAS  PubMed  Google Scholar 

  2. Boćkowski L, Sobaniec W, Kułak W, Smigielska-Kuzia J (2008) Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 60:542–548

    PubMed  Google Scholar 

  3. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2003) Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine. Cephalalgia 23:39–42

    Article  CAS  PubMed  Google Scholar 

  4. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2004) Flunarizine effects on oxidative stress in migraine patients. Cephalalgia 4:28–32

    Google Scholar 

  5. Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, Di Massimo C, Carolei A (2007) Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 27:1136–1141

    Article  CAS  PubMed  Google Scholar 

  6. Cowan J, Sinton CM, Varley AW, Wians FH, Haley RW, Munford RS (2001) Gene therapy to prevent organophosphate intoxication. Toxicol Appl Pharmacol 173:1–6

    Article  CAS  PubMed  Google Scholar 

  7. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L et al (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192–196

    Article  PubMed  Google Scholar 

  8. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S et al (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371–377

    Article  CAS  PubMed  Google Scholar 

  9. Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn, Cephalalgia, vol 24 Suppl 1, pp 1–160

  10. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73–76

    Article  CAS  PubMed  Google Scholar 

  11. Kucukali CI, Aydin M, Ozkok E, Orhan N, Cakir U, Kilic G et al (2008) Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population. Psychiatr Genet 18:289–294

    Article  PubMed  Google Scholar 

  12. La Du BN (1992) Human serum paraoxonase/arylesterase. In: Kalow W (ed) Pharmacogenetics of drugs metabolism. Pergamon Press, New York, pp 51–91

    Google Scholar 

  13. Li HL, Liu DP, Liang CC (2003) Paraoxonase gene polymorphisms, oxidative stress, and diseases. J Mol Med 81:766–779

    Article  CAS  PubMed  Google Scholar 

  14. Mackness B, Durrington PN, Mackness MI (2002) The paraoxonase gene family and coronary heart disease. Curr Opin Lipidol 13:357–362

    Article  CAS  PubMed  Google Scholar 

  15. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B et al (1998) Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 139:341–349

    Article  CAS  PubMed  Google Scholar 

  16. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA (1986) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7:69–76

    Article  Google Scholar 

  17. Ng DS, Chu T, Esposito B, Hui P, Connelly PW, Gross PL (2008) Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia. Cardiovasc Pathol 17:226–232

    Article  CAS  PubMed  Google Scholar 

  18. Ophoff RA, Terwint GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1Ar. Cell 87:543–552

    Article  CAS  PubMed  Google Scholar 

  19. Rasmussen BK (2006) Epidemiology of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincot Williams & Wilkins, Philadelphia, pp 235–242

    Google Scholar 

  20. Russell MD, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. BMJ 311:541–544

    CAS  PubMed  Google Scholar 

  21. Shimomura T, Kowa H, Nakano T, Kitano A, Marukawa H, Urakami K, Takahashi K (1994) Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 14:215–218

    Article  CAS  PubMed  Google Scholar 

  22. Shukla R, Barthwal MK, Srivastava N, Sharma P, Raghavan SA, Nag D et al (2004) Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 241:37–43

    Article  Google Scholar 

  23. Taffi R, Vignini A, Lanciotti C, Luconi R, Nanetti L, Mazzanti L et al (2005) Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia 25:353–358

    Article  CAS  PubMed  Google Scholar 

  24. Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, Marini C, Ciancarelli I, Carolei A (1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia 17:580–584

    Article  CAS  PubMed  Google Scholar 

  25. Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbiçer H (2008) Oxidative stress in migraine with and without aura. Biol Trace Elem Res 126:92–97

    Article  CAS  PubMed  Google Scholar 

  26. Yilmaz G, Sürer H, Inan LE, Coskun O, Yücel D (2007) Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 211:23–30

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by Grants FIS 05/1056, 06/1252 and RETICS RD07/0064/0016 from Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, and FUNDESALUD, Consejería de Sanidad y Consumo, Junta de Extremadura.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Félix Javier Jiménez-Jiménez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

García-Martín, E., Martínez, C., Serrador, M. et al. Paraoxonase 1 (PON1) polymorphisms and risk for migraine. J Neurol 257, 1482–1485 (2010). https://doi.org/10.1007/s00415-010-5551-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5551-2

Keywords

Navigation